|
Alzheimer's Disease in the News
Columbia researchers restore memory lost in mice with Alzheimer's
Boosting a newly discovered enzyme helps mice regain normal cognitive function
NEW YORK August 24, 2006 -- Researchers at Columbia University Medical Center have successfully restored normal memory and synaptic function in mice suffering from
Alzheimer's disease. The study was published today on the website of the journal Cell.
Scientists at Columbia's Taub Institute for Research on Alzheimer's Disease and the Aging Brain have identified an enzyme that is required for normal cognition
but that is impaired in a mouse model of Alzheimer's. They discovered that mice regained the ability to form new memories when the enzyme's function was elevated.
The research suggests that boosting the function of this enzyme, known as ubiquitin C-terminal hydrolase L1 (Uch-L1), may provide a promising strategy for battling
Alzheimer's disease, and perhaps reversing its effects.
In the new study, the Columbia researchers discovered that the enzyme Uch-L1 is part of a molecular network that controls a memory molecule called CREB, which is
inhibited by amyloid beta proteins in people with Alzheimer's. By increasing Uch-L1 levels in mice that had Alzheimer's, they were able to improve the animals' ability to create new memories.
"Because the amyloid beta proteins that cause Alzheimer's may play a normal, important physiological role in the body, we can't destroy them as a
therapy," explained Ottavio Arancio, M.D., Ph.D., Assistant Professor of Pathology at Columbia University Medical Center and co-principal investigator of the study with Michael Shelanski, MD, Ph.D.,
Chairman of the Department of Pathology at the Columbia University College of Physicians and Surgeons. "What makes this newly discovered enzyme exciting as a potentially effective therapy is that it
restores memory without destroying amyloid beta proteins."
The researchers tested the memory of the mice by putting them in a cage where they were exposed to a mild stimulus when they touched the cage floor. Mice with normal
memory remain still the second time they're placed in the cage, as they recognize the place where they were initially exposed to the stimulus. But mice with Alzheimer's-like changes do not
remember the place, and continue moving within the cage. When the Alzheimer's mice were treated with Uch-L1, they acted like normal mice, and remained still.
"While this discovery is very promising, its proven effectiveness is limited to animal models and it will take some time before it could lead to therapies in
humans," said Dr. Shelanski. "We continue to work towards that crucial goal." The work was supported by the National Institutes of Neurological Disease and Stroke and the Alzheimer's
Center Program of the National Institute of Aging.
Neuroimaging Study Describes Alzheimer's Disease-Like ... - Science Daily It was long thought that the formation of plaques injured and perhaps even caused the death of nerve cells in the brain. Recent studies, however, suggest that a form of the amyloid beta protein that is soluble rather than the form that is deposited ...
Healthy Outlook - Alzheimer's disease impacts everyone - Frederick News-Post BY THE TIME you finish reading this column (depending on how carefully you read it) one more person in America will be diagnosed with Alzheimer's disease. A new report from the Alzheimer's Association says that every 70 seconds someone is diagnosed ...
Alzheimer's 'epidemic' hitting minorities hardest - WMC-TV TUESDAY, March 9 (HealthDay News) -- Over 5 million Americans are living with Alzheimer's disease, and blacks and Hispanics are at highest risk of developing the disease, a new report finds. The report, 2010 Alzheimer's Disease Facts and Figures ...
QUERENCIA AT BARTON CREEK AND SQLC CHARITABLE ... - dBusinessNews.com The hard work and determination they contribute each day towards the fight against Alzheimer’s disease is commendable and worthy of praise.” In accepting the donation, Christian Wells , vice president of programs at The Capital of Texas Chapter ...
120,000 Tennesseans have Alzheimer's Disease - WATE NASHVILLE (WATE/AP) - The Alzheimer's Association says 120,000 persons have the disease in Tennessee and the figure is projected to be 140,000 by 2025. Alzheimer's disease is a progressive and fatal disease of the brain. As many as 5.3 million ...
Early Identification of Alzheimer's Disease With PET ... - Investors Business Daily LOS ANGELES, March 16, 2010 /PRNewswire via COMTEX/ -- Westside Medical Associates of Los Angeles and Westside Medical Imaging (WMI) of Beverly Hills announce the benefit of early positron emission tomography (PET) scanning to identify Alzheimer's in ...
Fruit Flies and Test Tubes Open New Window on Alzheimer ... - Science Daily ScienceDaily (Mar. 16, 2010) — A team of scientists from Cambridge and Sweden have discovered a molecule that can prevent a toxic protein involved Alzheimer's disease from building up in the brain. They found that in test tube studies the molecule ...
New Study Suggests Moderate Exercise May Increase ... - Earthtimes ... CEO Colin Milner says that these results are the latest in a growing body of research that implies preventative measures can help keep the brain healthy and ward off Alzheimer's disease and other forms of dementia. "This research represents ...
Using new approach, Mayo Clinic researchers find level ... - Genetic Engineering News JACKSONVILLE, Fla. Using sophisticated techniques that scan the genomes of patients, researchers at the Mayo Clinic campus in Florida have found that a gene appears to either help protect against development of Alzheimer's disease, or promote the ...
Dementia, Alzheimer’s, Lewy Body Disease - the ... - Examiner Get alerts when there is a new article from the Pittsburgh Elder Care Examiner. Read Examiner.com's terms of use. There is just so much confusion about afflictions of the brain that we generally attribute to just being "old". Alzheimer’s Disease ...
|
|